MedPath

iquid biopsies for improving the pre-operative diagnosis of ovarian cancer

Recruiting
Conditions
cancer of the ovary
ovarian cancer
10038594
10029903
Registration Number
NL-OMON51106
Lead Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
450
Inclusion Criteria

1. Age >=18 years
2. Presence of a ovarian tumor and referred to specialized center for surgery
based on:
a. Any ultrasound model
b. Subjective assessment of the referring gynecologist
c. Normal Glomerular Filtration Rate (GFR): >60ml/min/1,73m2
3.General criteria:
a. Understanding of Dutch language
b. Fit for surgery (WHO 1-2)
c. Written informed consent

Exclusion Criteria

1. Suspicion of advanced-stage of disease, e.g. ascites or peritoneal
depositions
2. History of cancer (excl. BCC) within 5 years prior to inclusion
3. Multiple malignancies at the same time

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The sensitivity and specificity of a new diagnostic algorithm including liquid<br /><br>biopsies, to differentiate patients with ovarian cancer from patients with a<br /><br>benign ovarian tumor. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1. Calculation of cost-effectiveness of addition of plasma liquid biopsy<br /><br>measurement in the triage of patients with an ovarian tumor.<br /><br>2. Psychological burden of the uncertainty of having cancer or not before<br /><br>surgical treatment. </p><br>
© Copyright 2025. All Rights Reserved by MedPath